IDH1 and cancer: TCGAnalyzeR integrated the multi-omics, pan-cancer TCGA with ~120 subcohorts from the literature along with clipboard panels, thus allowing users to create their own subcohorts, compare against existing external subcohorts (MSI, Immune, PAM50, Triple Negative, IDH1, miRNA, metastasis, etc.)along with our internal patient clusters, and visualize cohort-centric or gene-centric results interactively using TCGAnalyzeR.